376 related articles for article (PubMed ID: 32294860)
21. [Variations of gut microbiome composition under different preservation solutions and periods].
Duan Y; Lü N; Cai F; Zhu B
Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2525-2540. PubMed ID: 33398951
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota in patients with Parkinson's disease in southern China.
Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
[TBL] [Abstract][Full Text] [Related]
23. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
[TBL] [Abstract][Full Text] [Related]
24. Microbiota bacteriana intestinal en pacientes mexicanos con inmunodeficiencia común variable.
Franco-Esquivias AP; García-De la Peña C; Torres-Lozano C; Vaca-Paniagua F; Díaz-Velásquez C; Ortega-Cisneros M; Quintero-Ramos A
Gac Med Mex; 2019; 155(5):481-486. PubMed ID: 31695233
[TBL] [Abstract][Full Text] [Related]
25. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
[TBL] [Abstract][Full Text] [Related]
26.
Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049578
[TBL] [Abstract][Full Text] [Related]
27. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
[TBL] [Abstract][Full Text] [Related]
28. Characterizing the fecal microbiota of infants with botulism.
Shirey TB; Dykes JK; Lúquez C; Maslanka SE; Raphael BH
Microbiome; 2015 Nov; 3():54. PubMed ID: 26593441
[TBL] [Abstract][Full Text] [Related]
29. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
[TBL] [Abstract][Full Text] [Related]
30. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
Cilia R; Piatti M; Cereda E; Bolliri C; Caronni S; Ferri V; Cassani E; Bonvegna S; Ferrarese C; Zecchinelli AL; Barichella M; Pezzoli G
J Parkinsons Dis; 2021; 11(1):159-170. PubMed ID: 33337387
[TBL] [Abstract][Full Text] [Related]
31. Changes in the intestinal microbiota of patients with Parkinson's disease and their clinical significance.
Zhang LN; Yuan WL; Ye M; Yin L; Wang SJ
Int J Clin Pharmacol Ther; 2023 Feb; 61(2):48-58. PubMed ID: 36420886
[TBL] [Abstract][Full Text] [Related]
32. The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease.
Shi J; Wang Y; Chen D; Xu X; Li W; Li K; He J; Su W; Luo Q
Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1917-1929. PubMed ID: 36795141
[TBL] [Abstract][Full Text] [Related]
33. Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study.
Zapała B; Stefura T; Wójcik-Pędziwiatr M; Kabut R; Bałajewicz-Nowak M; Milewicz T; Dudek A; Stój A; Rudzińska-Bar M
J Clin Med; 2021 Dec; 10(23):. PubMed ID: 34884399
[TBL] [Abstract][Full Text] [Related]
34. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction.
Hu J; Li P; Zhao H; Ji P; Yang Y; Ma J; Zhao X
J Ethnopharmacol; 2024 Jan; 318(Pt A):116893. PubMed ID: 37423520
[TBL] [Abstract][Full Text] [Related]
35. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China.
Li C; Huang Q; Yang R; Dai Y; Zeng Y; Tao L; Li X; Zeng J; Wang Q
Osteoporos Int; 2019 May; 30(5):1003-1013. PubMed ID: 30666372
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the composition and functions of the oral and gut microbiotas in Alzheimer's patients.
Chen L; Xu X; Wu X; Cao H; Li X; Hou Z; Wang B; Liu J; Ji X; Zhang P; Li H
Front Cell Infect Microbiol; 2022; 12():942460. PubMed ID: 36093178
[TBL] [Abstract][Full Text] [Related]
38. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
[TBL] [Abstract][Full Text] [Related]
39. Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson's Disease.
Li Z; Lu G; Li Z; Wu B; Luo E; Qiu X; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Cai Q; Xu Y; Chen Y; Wang M; Poon WS; Luo X
Front Immunol; 2021; 12():632482. PubMed ID: 34276644
[TBL] [Abstract][Full Text] [Related]
40. Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.
Proano AC; Viteri JA; Orozco EN; Calle MA; Costa SC; Reyes DV; German-Montenegro M; Moncayo DF; Tobar AC; Moncayo JA
Neurol Int; 2023 Jun; 15(2):750-763. PubMed ID: 37368331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
